GIII-SPLA2; sPLA2-III; Group 3 secretory phospholipase A2; Group III secretory phospholipase A2; Phosphatidylcholine 2-acylhydrolase 3
GIII-SPLA2; sPLA2-III; Group 3 secretory phospholipase A2; Group III secretory phospholipase A2; Phosphatidylcholine 2-acylhydrolase 3
PLD1C; Choline Phosphatase 2; Phosphatidylcholine-hydrolyzing phospholipase D2
PLD1C; Choline Phosphatase 2; Phosphatidylcholine-hydrolyzing phospholipase D2
GOT2; MitAAT; KATIV; KAT4; FABP-1; Plasma membrane-associated fatty acid-binding protein; Glutamic-Oxaloacetic Transaminase 2,Mitochondrial; Kynurenine Aminotransferase IV
GOT2; MitAAT; KATIV; KAT4; FABP-1; Plasma membrane-associated fatty acid-binding protein; Glutamic-Oxaloacetic Transaminase 2,Mitochondrial; Kynurenine Aminotransferase IV
GPCR135; RLN3R1; SALPR; RXFPR3; Relaxin 3 Receptor 1; G-protein coupled receptor GPCR135; Somatostatin- and angiotensin-like peptide receptor
GPCR135; RLN3R1; SALPR; RXFPR3; Relaxin 3 Receptor 1; G-protein coupled receptor GPCR135; Somatostatin- and angiotensin-like peptide receptor
H2; RLXH2; Relaxin H2; Prorelaxin H2; Relaxin,Ovarian,Of Pregnancy; Prorelaxin H2
H2; RLXH2; Relaxin H2; Prorelaxin H2; Relaxin,Ovarian,Of Pregnancy; Prorelaxin H2